Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hafsa Al-Azzawi"'
Autor:
Dana A. Alqudah, Hafsa Al-Azzawi, Lobna Gharaibeh, Mamoun Souleiman, Abdalla Awidi, Arwa Alkaraki, Walhan Alshaer, Duaa Abuarqoub, Suha Wehaibi, Hadil Zureigat
Publikováno v:
Breast Cancer. 27:989-998
The absence of receptors in triple-negative breast cancer limits therapeutic choices utilized in clinical management of the disease. Doxorubicin is an important member of therapeutic regimens that is hindered by emergence of resistance. The current w
Autor:
Rand Zaza, Abeer Al Bawab, Walhan Alshaer, Duaa Abuarqoub, Said I. Ismail, Hamdi Nsairat, Malak I. Qadri, Ismail S. Mahmoud, Hafsa Al-Azzawi, Fadwa Odeh, Abdalla Awidi
Publikováno v:
RSC Advances. 10:36219-36229
A new combination strategy of an active loading and active targeting approach was applied in this work. The liposomes actively loaded with Curcumin (CRM) (LipCRM) were decorated with cholesterol tagged-anti-nucleolin AS1411 aptamer (NCL) via a new po
Autor:
Hafsa Al-Azzawi, Walhan Alshaer, Ezaldeen Esawi, Zainab Lafi, Duaa Abuarqoub, Rand Zaza, Manar Zraikat, Abdelkader Battah, Abdalla Awidi
Publikováno v:
Journal of Drug Delivery Science and Technology. 69:103169
Autor:
Lobna Gharaibeh, Dana A. Alqudah, Suha Wehaibi, Yasser Bustanji, Abdalla Awidi, Hafsa Al-Azzawi, Abdulfattah Al-Kadash, Rula Al Buqain, Walhan Alshaer
Publikováno v:
Journal of Drug Delivery Science and Technology. 65:102733
Triple negative breast cancer is an aggressive type of cancer with limited therapeutic options. Aptamer-functionalized liposomes to deliver short interference RNAs (siRNAs) offer a promising therapeutic option. The current study aimed at preparing an